Back to Search Start Over

Cortisol and cardiometabolic disease: a target for advancing health equity.

Authors :
Ortiz R
Kluwe B
Lazarus S
Teruel MN
Joseph JJ
Source :
Trends in endocrinology and metabolism: TEM [Trends Endocrinol Metab] 2022 Nov; Vol. 33 (11), pp. 786-797. Date of Electronic Publication: 2022 Oct 18.
Publication Year :
2022

Abstract

Stress, in both intrinsic psychosocial and extrinsic physical environmental forms, can impact the development of, and outcomes in, cardiovascular disease (CVD) through allostatic load. Cortisol is a core hormonal mediator of allostatic load produced in response to various stresses. Alterations in morning serum cortisol and daily diurnal cortisol have been associated with adiposity, dyslipidemia, incident diabetes, and CVDs such as hypertension. The review examines the role of cortisol as a key mechanistic link between stress physiology and cardiometabolic disease. Importantly, we discuss the role of targeting cortisol through pharmacological, behavioral, and environmental interventions to advance health equity in cardiometabolic disease.<br />Competing Interests: Declaration of interests The authors have no conflicts of interest to declare.<br /> (Copyright © 2022 Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1879-3061
Volume :
33
Issue :
11
Database :
MEDLINE
Journal :
Trends in endocrinology and metabolism: TEM
Publication Type :
Academic Journal
Accession number :
36266164
Full Text :
https://doi.org/10.1016/j.tem.2022.08.002